Avantor, Inc.

$16.68$0.39 (+2.41%)
Last updated on --.

Avantor, Inc. price

24 Hours+2.41%+$0.392
30 days+9.98%+$1.507
60 days+12.66%+$1.830
90 days+46.32%+$5.257

About Avantor, Inc.

Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.

Stock ticker
AVTR
Company
Avantor, Inc.
Industry
Healthcare
Category
US
Stock split / reverse split
--
Launch date
May 17, 2019
Listed exchange
NYSE

Financials

Q2 FY2026 Earnings
Report period: Apr 1, 2026 – Jun 30, 2026

Summary: AVTR reported Revenue of 1.69B (+0.53%), beating expectations; EPS of 0.21 (-12.50%), beating expectations.

Revenue (USD)Beat1.69B+0.52%1.61B-2.16%81.59M+5.06%
EPS (USD)Beat0.21-12.50%0.19-23.40%0.02+9.66%
Financial estimates
● Actual● Estimate
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
0.09-1.040.080.060.06
-32.22%-1,329.32%-89.44%-32.60%-36.78%
● EPS● YoY
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
12.78B11.68B11.79B11.66B11.60B
6.49B6.11B6.23B6.07B5.97B
50.80%52.29%52.81%52.08%51.44%
● Assets● Liabilities● Ratio
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
154.40M207.40M152.70M58.70M178.20M
-45.08%-15.28%-11.89%-46.30%+15.41%
● CFO● YoY

Shareholders

Shareholders
DODGE & COX17.74%
BLACKROCK, INC.10.39%
VANGUARD PORTFOLIO MANAGEMENT LLC4.63%
VANGUARD CAPITAL MANAGEMENT LLC4.55%
GREENHAVEN ASSOCIATES INC3.64%
Others59.02%
Institutions
% Owned104.26%+4.60%
Shares held705.01M+29.32M
Institutions470+23
% OwnedPrice
Name% OwnedChange
DODGE & COX17.74%+372.65K
BLACKROCK, INC.10.39%+4.58M
VANGUARD PORTFOLIO MANAGEMENT LLC4.63%+67.40K
VANGUARD CAPITAL MANAGEMENT LLC4.55%+196.72K
GREENHAVEN ASSOCIATES INC3.64%+2.04M

Avantor, Inc. conversion tables

AVTRAVTR
USDUSD
0.5 AVTR8.341 USD
1 AVTR16.68 USD
5 AVTR83.41 USD
10 AVTR166.82 USD
USDUSD
AVTRAVTR
0.5 USD0.029972 AVTR
1 USD0.059945 AVTR
5 USD0.29972 AVTR
10 USD0.59945 AVTR

More to explore

FAQ

AVTR is trading at $16.68, +2.41% over the last 24 hours. Track live moves on the price chart at the top of this page.

The AVTR stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. AVTR is currently trading at $16.68, +2.41% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on AVTR price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the Healthcare sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.

P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. AVTR's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from AVTR; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against AVTR's historical range and other companies in the Healthcare sector.

Avantor, Inc.'s market cap is currently 11.16B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.